• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
39.29
37200.83
EPS(TTM)
Face Value()
Div & Yield %
75.78
2
0
 

Systematix Corporate Services invests Rs 35 cr in wholly owned subsidiary
Apr 13,2026
Systematix Corporate Services announced that the Company has made Investment through rights issue in its Wholly Owned Subsidiary i.e. M/s. Systematix Shares and Stocks (India) aggregating to Rs. 35 crore by subscribing to 17,50,036 equity shares of face value of Rs. 10/- each at an issue price of Rs. 200/- (including premium of Rs. 190/-) per equity share.